Hamed Sajjadi, MD
Otology & Neurotology · Stanford, CANPI 1336169259
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $837 of the $1,041 with a category attached, or 80.4%. 11 manufacturers reported payments, led by Med-el Corporation at 25.9% of the total. Reporting peaked in 2019 at $439 and has fallen 56.8% since, to $190 in 2025. That places this record below the midpoint for otology & neurotology clinicians in CA, where the typical reported total is $1,509.
Across 14 payments — averaging $74.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Med-el Corporation$270
- Neurent Medical Limited$201
- Pfizer$125
- Sanofi$122
- Intersect ENT, Inc.$101
- Medtronic$65
- plus $158 from 5 others
What the payments were for
- Travel & lodging$20420%
- Food & beverage$83780%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Med-el Corporation | 2 | $270 |
| Neurent Medical Limited | 1 | $201 |
| Pfizer | 1 | $125 |
| Sanofi | 1 | $122 |
| Intersect ENT, Inc. | 1 | $101 |
| Medtronic | 2 | $65 |
| Aerin Medical Inc. | 1 | $47 |
| Optinose US, Inc. | 2 | $47 |
| Stryker | 1 | $26 |
| Cochlear Americas | 1 | $23 |
| GSK | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,041 in reported general payments places this provider in the 45th percentile of 43 otology & neurotology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 12 | $1,213 |
| Ofloxacin | 24 | $767 |
| Clotrimazole | 20 | $614 |
| Clarithromycin | 14 | $598 |
| Cefdinir | 18 | $588 |
| Ciprofloxacin Hcl | 31 | $473 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 36 | $439 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 17 | $385 |
| Mometasone Furoate | 11 | $285 |
| Nortriptyline Hcl | 14 | $246 |
| Ondansetron OdtOndansetron | 12 | $243 |
| Fluconazole | 13 | $146 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $139 |
| Methylprednisolone | 15 | $111 |
| Ibuprofen | 21 | $104 |
Paid to pharmacies, not to this prescriber.
Other otology & neurotology in Stanford
- Lloyd MinorStanford$52K
- Sumit AgrawalStanford$21K
- Nikolas BlevinsStanford$6K
- Peter Santa MariaStanford$3K
- Jennifer AlyonoStanford$3K
- Lindsay MooreStanford$458
- Konstantina StankovicStanford$206
- Peter KullarStanford$76
- John Vaughanla Jolla$237K
- Rodney PerkinsWoodside$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.